Replies to post #19880 on Mymetics Corp (MYMX)

[Work Harder]

Zoom in & located in same building

https://en.wikipedia.org/wiki/Galapagos_NV

Its headquarters are located in Mechelen (in the province of Antwerp in the Flemish Region of Belgium} and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb. The CEO is the Dutchman Onno van de Stolpe

Galapagos Genomics NV was founded in 1999 as a joint venture between Crucell and Tibotec.[3] The company later changed its name to Galapagos NV and completed its initial public offering on Euronext Amsterdam and Euronext Brussels in May 2005

https://relationshipscience.com/person/menzo-havenga-4677085

Vice President-Research & Development
2001 - 2007
Janssen Vaccines & Prevention B.V.
Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems.Th...

https://relationshipscience.com/person/christopher-yallop-4677089

Director-Research & Development
2002 - 2008
Janssen Vaccines & Prevention B.V.
Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems.The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands.
- Show less

Senior Scientist
1996 - 2002
Novo Nordisk A/S
Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.